Processa Pharmaceuticals, Inc. PCSA Q4 2025 Annual earnings

FAQ

When did Processa Pharmaceuticals, Inc. report Q4 2025 earnings?

Processa Pharmaceuticals, Inc. (PCSA) reported Q4 2025 earnings on March 19, 2026 after market close.

What were Processa Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?

Processa Pharmaceuticals, Inc. reported eps of $-18.50 for Q4 2025.

Did Processa Pharmaceuticals, Inc. beat estimates in Q4 2025?

EPS missed the consensus estimate of $-1.50 by $17.00.

How did Processa Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps declined 2400.0% from $-0.74.

Where can I find Processa Pharmaceuticals, Inc.'s Q4 2025 SEC filings?

You can read the 10-K periodic report (0001493152-26-011204) directly on SEC EDGAR. The filing index links above go to sec.gov.